T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Mistras Group
MG
$492M
| $153K | ﹤0.01% |
+10,324
| New | +$149K |
|
2902
Resources Connection
RGP
$129M
| $153K | ﹤0.01% |
40,992
| – | – |
|
2903
Outset Medical
OM
$74.9M
| $152K | ﹤0.01% |
39,427
+10,800
| +38% | +$44.3K |
|
|
GPMT
2904
Granite Point Mortgage Trust
GPMT
$63.7M
| $151K | ﹤0.01% |
103,739
+18,200
| +21% | +$35K |
|
2905
Ribbon Communications
RBBN
$354M
| $149K | ﹤0.01% |
69,822
| – | – |
|
2906
The Oncology Institute
TOI
$498M
| $149K | ﹤0.01% |
48,271
+10,269
| +27% | +$31.5K |
|
2907
Candel Therapeutics
CADL
$700M
| $148K | ﹤0.01% |
30,110
+4,296
| +17% | +$23.4K |
|
|
MPX
2908
DELISTED
Marine Products Corp
MPX
| $148K | ﹤0.01% |
20,355
+4,200
| +26% | +$34.7K |
|
|
CTNM
2909
Contineum Therapeutics
CTNM
$526M
| $148K | ﹤0.01% |
11,300
| – | – |
|
|
BRCB
2910
Black Rock Coffee Bar Inc
BRCB
$170M
| $148K | ﹤0.01% |
11,421
+1,994
| +21% | +$32.3K |
|
2911
InnovAge Holding
INNV
$1.57B
| $147K | ﹤0.01% |
18,256
+6,757
| +59% | +$50.5K |
|
2912
Oportun Financial
OPRT
$257M
| $147K | ﹤0.01% |
31,733
+7,778
| +32% | +$39.6K |
|
2913
Reservoir Media
RSVR
$700M
| $147K | ﹤0.01% |
14,956
+4,835
| +48% | +$40.1K |
|
2914
Sky Harbour Group
SKYH
$351M
| $147K | ﹤0.01% |
15,220
+4,536
| +42% | +$41.8K |
|
2915
Red Robin
RRGB
$134M
| $146K | ﹤0.01% |
49,587
+10,500
| +27% | +$39.4K |
|
|
NXDT
2916
NexPoint Diversified Real Estate Trust
NXDT
$281M
| $145K | ﹤0.01% |
30,864
+11,709
| +61% | +$52.4K |
|
2917
Unisys
UIS
$227M
| $145K | ﹤0.01% |
69,884
+12,697
| +22% | +$31.9K |
|
2918
Acacia Research
ACTG
$450M
| $144K | ﹤0.01% |
29,937
+11,199
| +60% | +$47.2K |
|
2919
Frontier Group Holdings
ULCC
$1.34B
| $144K | ﹤0.01% |
40,583
-10,173
| -20% | -$46.5K |
|
2920
Universal Electronics
UEIC
$57.2M
| $143K | ﹤0.01% |
34,686
| – | – |
|
|
INV
2921
Innventure Inc
INV
$243M
| $143K | ﹤0.01% |
36,462
+20,719
| +132% | +$73.2K |
|
|
CV
2922
CapsoVision Inc
CV
$324M
| $143K | ﹤0.01% |
+19,550
| New | +$115K |
|
2923
AerSale
ASLE
$292M
| $142K | ﹤0.01% |
22,671
+5,303
| +31% | +$37.8K |
|
2924
Concrete Pumping Holdings
BBCP
$531M
| $141K | ﹤0.01% |
19,689
+7,354
| +60% | +$48.9K |
|
2925
OppFi
OPFI
$770M
| $140K | ﹤0.01% |
18,110
+3,221
| +22% | +$29.5K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.